BeOne Medicines AG
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| BEIGF | 688759.SS | 6855.HK | 688382.SS | GMAB | 0A3M.IL | |
|---|---|---|---|---|---|---|
| Market cap | 32.46B | 7.56B | 11.30B | 8.38B | 33.89B | 25.17B |
| P/E (TTM) | 51.0 | — | — | — | 43.4 | 5.1 |
| Forward P/E | — | — | -78.0 | -43.8 | 34.9 | 5.1 |
| Price/book | 6.2 | 4.9 | 17.3 | 6.6 | 5.5 | 1.1 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +37.59% | −52.52% | −56.77% | −48.70% | +91.12% | −13.17% |
| Today | 0.00% | +4.42% | +6.70% | +4.33% | −0.72% | +2.81% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All BEIGF news ›BeOne Medicines to Present at the Jefferies Global Healthcare Conference
Cipher, a Prosegur Company, and BIO-key Announce Technology Integration to Expand Identity Security Offering, Starting in Portugal Rising Dragon Acquisition Corp. and HZJL Cayman Limited Announce Mutual Termination of Merger Agreement…
BeOne Medicines Ltd. – Sponsored ADR (NASDAQ:ONC) Stock Has Consensus Target Price of $407.07
Posted by Kim Johansen on Nov 2nd, 2026 View Our Latest Research Report on BeOne Medicines Its portfolio includes BRUKINSA (zanubrutinib), a Bruton’s tyrosine kinase inhibitor used in the treatment of several blood cancers, and TEVIMBRA…
BeOne Medicines: Brukinsa And Tevimbra Face A High Bar
BeOne Medicines AG’s oncology growth is fueled by Tevimbra and a deep pipeline, but its premium valuation tempers upside. Click for more on ONC stock. - BeOne Medicines AG is a fast-growing oncology company and a Wall Street favorite. -…
BeOne Medicines (ONC) Liver Cancer Drug Achieves 36% Response in Early Trial Data
BeOne Medicines AG, ONC BeOne Medicines shared refreshed Phase 1 data for BGB-B2033, a novel agent developed for patients with advanced hepatocellular carcinoma. The therapy produced a 36% confirmed objective response rate when…
BeOne Medicines (NASDAQ:ONC) Hits New 52-Week High – Should You Buy?
Posted by Kim Johansen on Oct 21st, 2026 BeOne Medicines Ltd. – Sponsored ADR (NASDAQ:ONC – Get Free Report) shares hit a new 52-week high on Wednesday. The stock traded as high as $386.87 and last traded at $386.2450, with a volume of…
BeOne Medicines director sells 31,027 depositary shares
3 E Network Signs Core 9 MVA Power Distribution Agreement for Mikkeli AI Compute Center in Finland J-Star Holding Co., Ltd. Advances U.S. Drone Manufacturing Initiative; Negotiates Acquisition of Facility in the Greater Houston Area Merck…
BeOne Medicines Highlights Rapidly Accelerating Solid Tumor Franchise at ESMO 2026
BeOne Medicines (ONC) will present solid tumor pipeline and TEVIMBRA data at the ESMO Congress on October 23–27, 2026, in Madrid. New data from four priority programs, including the GPC3x4-1BB bispecific antibody, CEA targeting ADC, CDK4…
BeOne Medicines (NASDAQ:ONC) Insider Sells $10,890,166.73 in Stock
Posted by Defense World Staff on Oct 18th, 2026 Xiaodong Wang also recently made the following trade(s): Get Our Latest Report on ONC BeOne Medicines Ltd. (NASDAQ: ONC) is a global oncology company focused on discovering, developing,…
TB Alternative Assets Ltd. Makes New $5.42 Million Investment in BeOne Medicines Ltd. - Sponsored ADR $ONC
Check Out Our Latest Stock Report on ONC BeOne Medicines Ltd. NASDAQ: ONC is a global oncology company focused on discovering, developing, manufacturing and commercializing medicines for people with cancer. The company operates across the…
Sanders Morris Harris LLC Makes New Investment in BeOne Medicines Ltd. - Sponsored ADR $ONC
Sanders Morris Harris LLC bought a new position in shares of BeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC - Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- themarketsdaily.com4
- marketbeat.com3
- stocktitan.net2
- defenseworld.net1
- pharmaphorum.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 12 articles, not a forecast.